{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:11:05Z","timestamp":1791943865600,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ymgme.2025.109139","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T14:22:29Z","timestamp":1747578149000},"page":"109139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sphingolipid de novo synthesis is upregulated in a macrophage model of Gaucher disease"],"prefix":"10.1016","volume":"145","author":[{"given":"Ashleigh","family":"Lake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109139_bb0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109139_bb0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ymgme.2025.109139_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ymgme.2007.11.011","article-title":"Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease","volume":"93","author":"Fuller","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109139_bb0020","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2025.109139_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1203\/00006450-199601000-00020","article-title":"Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease","volume":"39","author":"Sidransky","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2025.109139_bb0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cca.2007.12.001","article-title":"Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease","volume":"389","author":"Ghauharali-van der Vlugt","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109139_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02024331","article-title":"Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses","volume":"149","author":"Harzer","year":"1989","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109139_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcmd.2014.01.005","article-title":"Gaucher disease: plasmalogen levels in relation to primary lipid abnormalities and oxidative stress","volume":"53","author":"Moraitou","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2025.109139_bb0045","first-page":"72","article-title":"Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention","volume":"1781","author":"Groener","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. of Lipids"},{"key":"10.1016\/j.ymgme.2025.109139_bb0050","first-page":"e118","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.ymgme.2025.109139_bb0055","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bcmd.2007.10.004","article-title":"Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention","volume":"40","author":"Meikle","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2025.109139_bb0060","first-page":"3181","article-title":"Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome","volume":"114","author":"Campeau","year":"2009","journal-title":"Blood, J. Am. Soc. of Hematol."},{"key":"10.1016\/j.ymgme.2025.109139_bb0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fcell.2019.00210","article-title":"Monitoring the sphingolipid de novo synthesis by stable-isotope labeling and liquid chromatography-mass spectrometry","volume":"7","author":"Wigger","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2025.109139_bb0070","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1016\/j.jmb.2016.06.013","article-title":"Determining the turnover of glycosphingolipid species by stable-isotope tracer lipidomics","volume":"428","author":"Skotland","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2025.109139_bb0075","doi-asserted-by":"crossref","first-page":"E416","DOI":"10.1152\/ajpendo.00457.2017","article-title":"Quantifying ceramide kinetics in vivo using stable isotope tracers and LC-MS\/MS","volume":"315","author":"Chen","year":"2018","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2025.109139_bb0080","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.molmet.2016.04.003","article-title":"A comprehensive lipidomic screen of pancreatic \u03b2-cells using mass spectroscopy defines novel features of glucose-stimulated turnover of neutral lipids, sphingolipids and plasmalogens","volume":"5","author":"Pearson","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymgme.2025.109139_bb0085","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1194\/jlr.D081646","article-title":"Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry","volume":"59","author":"Snider","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109139_bb0090","article-title":"Dihydrosphingosine driven enrichment of sphingolipids attenuates TGF\u03b2 induced collagen synthesis in cardiac fibroblasts","volume":"35","author":"Magaye","year":"2021","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ymgme.2025.109139_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BJ20111929","article-title":"Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1","volume":"444","author":"Schnute","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2025.109139_bb0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-291X(88)80037-8","article-title":"Rapid turnover of sphingosine synthesized de novo from [14C] serine by Chinese hamster ovary cells","volume":"157","author":"Medlock","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2025.109139_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/teb-2024-2006","article-title":"Metabolomic and proteomic applications to exercise biomedicine","volume":"1","author":"Wilkinson","year":"2024","journal-title":"Transl. Exerc. Biomed."},{"key":"10.1016\/j.ymgme.2025.109139_bb0110","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1194\/jlr.R800012-JLR200","article-title":"Thematic review series: sphingolipids. Biodiversity of sphingoid bases (\u201csphingosines\u201d) and related amino alcohols","volume":"49","author":"Pruett","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109139_bb0115","doi-asserted-by":"crossref","first-page":"38568","DOI":"10.1074\/jbc.M110.170621","article-title":"Kdo2-lipid a, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264. 7 macrophages, which is essential for induction of autophagy","volume":"285","author":"Sims","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109139_bb0120","first-page":"63","article-title":"Skin fibroblast metabolomic profiling reveals that lipid dysfunction predicts the severity of Friedreich\u2019s ataxia","author":"Wang","year":"2022","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109139_bb0125","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1194\/jlr.D015586","article-title":"Factors to consider in using [UC] palmitate for analysis of sphingolipid biosynthesis by tandem mass spectrometry","volume":"52","author":"Haynes","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109139_bb0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymgme.2007.08.001","article-title":"Secondary sphingolipid accumulation in a macrophage model of Gaucher disease","volume":"92","author":"Hein","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109139_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0076-6879(00)12921-0","article-title":"Effects of sphingosine and other sphingolipids on protein kinase C","volume":"312","author":"Smith","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymgme.2025.109139_bb0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109139_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/jnc.13976","article-title":"Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (hurler syndrome) mouse: impact of diet","volume":"141","author":"Saville","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2025.109139_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41531-022-00363-2","article-title":"Elevation of gangliosides in four brain regions from Parkinson\u2019s disease patients with a GBA mutation","volume":"8","author":"Blumenreich","year":"2022","journal-title":"npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.ymgme.2025.109139_bb0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jnr.490380214","article-title":"Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose: ceramide galactosyltransferase","volume":"38","author":"Stahl","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2025.109139_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1471-4159.1966.tb06794.x","article-title":"The lipid composition of purified bovine brain myelin","volume":"13","author":"Norton","year":"1966","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2025.109139_bib171","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB life"},{"key":"10.1016\/j.ymgme.2025.109139_bb0165","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3390\/ijms22115793","article-title":"A comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis","volume":"22","author":"Quinville","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109139_bb0170","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s42255-019-0134-8","article-title":"Metabolic messengers: ceramides","volume":"1","author":"Summers","year":"2019","journal-title":"Nat. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:09:31Z","timestamp":1749262171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225001301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1096719225001301"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109139","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingolipid de novo synthesis is upregulated in a macrophage model of Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109139"}}